Spyre Therapeutics grants inducement equity awards of 21,424 stock options and 6,604 RSUs to new hires

• Spyre Therapeutics granted inducement equity awards to two non-executive employees under its 2018 Equity Inducement Plan.
• Awards cover stock options for 21,424 shares, plus 6,604 restricted stock units.
• Options carry a 10-year term, priced at $89.93 per share, the Oct. 1 closing price.
• Option vesting starts with 25% at year one, then monthly; RSUs vest 25% on scheduled quarterly anniversaries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021605PRIMZONEFULLFEED9838745) on October 02, 2026, and is solely responsible for the information contained therein.